Transdermal therapeutic systems
Mutschler, E.; Langguth, P.
Fortschritte der Medizin 105(29): 571-574
1987
ISSN/ISBN: 0015-8178 PMID: 3679053 Document Number: 296498
Document emailed within 1 workday
Related Documents
Niedner, R. 1988: Transdermal therapeutic systems (TTS) Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 39(12): 761-766Pflegel, P.; Dittgen, M. 1987: Drugs and the body (VI)--Transdermal therapeutic systems Die Pharmazie 42(12): 799-809
Csóka, G.; Pásztor, E.; Marton, S.; Zelkó, R.án.; Antal, I.; Klebovich, I. 2007: Formulation of thermoresponsive transdermal therapeutic systems using cellulose derivatives Acta Pharmaceutica Hungarica 77(2): 102-107
Rehula, M. 1992: The effect of additives on the availability of atropine in transdermal therapeutic systems Ceskoslovenska Farmacie 40(8-10): 230-233
Kramar, M.; Giersch, K.H.; Schneider, H.T. 1987: Transdermal therapy of stable angina pectoris. Comparison of 2 different transdermal systems Fortschritte der Medizin 105(17): 340-342
Harrison, L.I.; Riedel, D.J. 1991: Transdermal nitroglycerin systems: methods for comparison Clinical Therapeutics 13(3): 361-367
Aiache, J.M. 1997: Transdermal therapeutic methods Annales de Cardiologie et d'Angeiologie 46(7): 441-449
Junginger, H.E. 1992: Formulation aspects on dermatological preparations and transdermal drug delivery systems Acta Pharmaceutica Nordica 4(2): 117
Sariev, A.K.; Zherdev, V.P.; Sologova, S.S.; Litvin, A.A.; Rodionov, A.P.; Kolyvanov, G.B.; Vasil'ev, A.E. 1999: Cytisine pharmacokinetics when used in a transdermal therapeutic system in rabbits Eksperimental'naia i Klinicheskaia Farmakologiia 62(6): 59-61
Monti, D.; Galli-Angeli, D.; Giannaccini, B.; Saettone, M.F. 1993: Setup and evaluation "in vitro" of a transdermal therapeutic system Bollettino Chimico Farmaceutico 132(2): 58-59
Khurmi, N.S.; O'Hara, M.J.; Bowles, M.J.; Whittington, J.R.; Lahiri, A.; Raftery, E.B. 1986: Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris British Journal of Clinical Practice 40(5): 187-191
Pfister, W.R.; Hsieh, D.S. 1990: Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations Medical Device Technology 1(6): 28-33
Litvin, A.A. 2004: Experimental pharmacokinetics of phenazepam during transdermal administration of the therapeutic phenaperkuten system Eksperimental'naia i Klinicheskaia Farmakologiia 67(2): 59-62
Gruber, D.; Skřivánek, A.; Serrani, M.; Lanius, V.; Merz, M. 2015: A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study Contraception 91(2): 105-112
Alfaya, T.; Mur Gimeno, P.; Iglesias, A.M.; Ventura, P.ón. 2011: Allergic contact dermatitis caused by an ethinylestradiol-norelgestromin transdermal therapeutic system Contact Dermatitis 64(4): 242-244
Solenkova, A.V.; Imaev, A.A.; Bondarenko, A.A.; Lubnin, A.Iu. 2011: Analysis of efficacy and safety of preventive analgesia with transdermal therapeutic system Duragesic Matrix in spine surgery Anesteziologiia i Reanimatologiia 2011(4): 32-37
Foldvari, M.; Baca-Estrada, M.E.; He, Z.; Hu, J.; Attah-Poku, S.; King, M. 1999: Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha Biotechnology and Applied Biochemistry 30(2): 129-137
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Lorvidhaya, V.; Katanyoo, K.; Srisomboon, J.; Suprapaphorn, P.; Cheewakriangkrai, C. 2004: Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain Journal of the Medical Association of Thailand 87(3): 319-325